Catalyst Funds Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.07M Buy
23,900
+18,161
+316% +$4.23M 0.34% 81
2026
Q1
$1.4M Buy
+5,739
New +$1.34M 0.24% 118
2025
Q4
Sell
-7,900
Closed -$1.46M 462
2025
Q3
$1.46M Buy
+7,900
New +$1.35M 0.22% 108
2025
Q2
Sell
-5,400
Closed -$896K 578
2025
Q1
$896K Buy
+5,400
New +$845K 0.23% 122
2024
Q4
Sell
-7,800
Closed -$1.26M 805
2024
Q3
$1.26M Buy
7,800
+7,100
+1,014% +$1.13M 0.28% 63
2024
Q2
$102K Buy
+700
New +$104K 0.03% 287

Other funds holding JNJ

Catalyst Funds Management's JNJ Position: Q2 2026 in Review

Catalyst Funds Management increased its Johnson & Johnson (JNJ) stake by 316% in Q2 2026, buying an estimated $4.23M and bringing the position to 23,900 shares worth $6.07M. The position accounts for 0.34% of the portfolio, ranked #81.

Catalyst Funds Management first reported a position in JNJ in Q2 2024 and has held it in 6 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Catalyst Funds Management held 23,900 shares of Johnson & Johnson worth $6.07M as of Q2 2026.
  • Catalyst Funds Management bought 18,161 Johnson & Johnson shares in Q2 2026, an estimated $4.23M.
  • Johnson & Johnson made up 0.34% of Catalyst Funds Management's portfolio in Q2 2026, its #81 holding.
  • Catalyst Funds Management first reported a position in Johnson & Johnson in Q2 2024 and has held it in 6 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.